Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft

Sep.19.2024
Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft
Indonesia's Health Ministry is asked to suspend discussions on tobacco and e-cigarette safety regulations, sparking industry concerns.

According to a report from Metrotv News on September 18, the Indonesian Ministry of Health has been asked to suspend discussions on the draft of the 2024 Tobacco and E-cigarette Product Safety Regulation (RPMK). The regulation has been criticized for restricting the market space for tobacco and e-cigarette products, and potentially harming Indonesia's tobacco farming and tobacco industry chain.


According to reports, this suggestion was put forward during a national dialogue event held at the Ashley Hotel in Jakarta on September 17 by pesantren and the Community Development Center (P3M).


The event was attended by a total of 50 representatives from government agencies, farmers' associations, trade unions, retailers associations, businesses, tobacco industry associations, civil society alliances, academia, religious leaders, and media. P3M Director Sarmidi Husna expressed concerns about the RPMK 2024 draft primarily due to its proposed plain packaging regulations, which are seen as restrictive to the tobacco industry. Husna noted that there was insufficient public participation in the drafting process, making it unrepresentative.


Husna further explained that some provisions in the draft may cause harm to tobacco farmers, small and medium-sized enterprises, various associations, and the tobacco industry, triggering strong opposition from various parties.


Benguet Saragih, from the Disease Control Working Group at the Ministry of Health, clarified that RPMK 2024 is not aimed at getting people to quit smoking, but rather is intended to prevent children from smoking.


In response, the Chairman of the National Association of Islamic Scholars (PBNU), Miftah Faqih, emphasized that the process of formulating any laws must include a balanced participation from all parties and focus on the common good, otherwise these laws will be ineffective and unfair. The representative of the Ministry of Industry, Nugraha Prasetya Yogi, also stated that the Ministry of Industry was not included in the previous law-making process, which is very detrimental to trade and industry.


Union representative Sudarto pointed out that since the enactment of the 2003 Health Law and Government Regulation No. 28 of 2004, tobacco regulations have gradually been implemented, significantly impacting the tobacco leaf and tobacco products industry. Sudarto emphasized that industrial policies and tax policies have also been used to suppress legal tobacco consumption, leading to the frequent appearance of illegal tobacco products.


Gunawan from the Indonesian Commission for Social Justice and Human Rights (IHCS) is calling for the coordination of existing regulations and laws to protect the interests of tobacco farmers. Indonesian parliament member Muhammad Misbakhun mentioned that the influence of international giants has caused local economies and tobacco farmers to go bankrupt, and therefore calls for the government to be a facilitator in finding a solution to the problem.


Representatives from the Indonesian Tobacco Association, Budiman, believe that restricting the sale of tobacco products will have negative effects on production, employment, and raw material sourcing. Additionally, Kusnasi Mudi, the Secretary General of the National Tobacco Growers Association (APTI), also stated that the government needs to reexamine this regulation and communicate with the entire industry chain to prevent significant impact on the future development of the industry.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
Acme Vape Ltd, the company behind UK vaping brand IVG, has received HM Revenue & Customs approval to operate an excise warehouse for vaping products and participate in the Vaping Duty Stamps Scheme. The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Acme Vape Ltd says its approved warehouse in Preston will become operational under the new regime on the same date.
Regulations
Sep.18 by 2Firsts Perspectives
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
2FIRSTS EXCLUSIVE|China Breaks Up $6.8 Million Illegal Hookah Tobacco Operation as Market Expands
2FIRSTS EXCLUSIVE|China Breaks Up $6.8 Million Illegal Hookah Tobacco Operation as Market Expands
Chinese authorities have dismantled an illegal hookah tobacco operation worth more than 46 million yuan ($6.8 million), detaining five foreign suspects and seizing over 500,000 boxes of tobacco paste. The case comes as hookah expands across China’s nightlife sector and attracts overseas operators, including former vaping entrepreneurs. It also raises a central regulatory question: whether waterpipe tobacco will follow China’s private-sector e-cigarette licensing model or be reserved for the state tobacco system, as with nicotine pouches, in the years ahead.
Jul.31
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Smoore’s first-half 2026 revenue rose 19.9%, but the results revealed growing structural risks beneath the headline growth. Heat-not-burn contributed about 61% of incremental revenue and remains driven largely by one core customer, while traditional vaping markets diverged, own-brand growth slowed and China enterprise revenue declined further. Gross profit and adjusted profit lagged revenue growth, while second-quarter revenue growth slowed to about 1.9%, putting greater focus on the quality, concentration and sustainability of Smoore’s expansion.
Capital Markets
Aug.20